Building a $862 billion industry player: how INB.bio is scaling from startup to 15-country wellness network in 6 years
The global dietary supplements and wellness market is projected to hit $862 billion according to Grand Viewers research. And yet most companies in the space are fighting over the same saturated markets, the same tired audiences, and the same increasingly expensive traffic. INB.bio went the other direction.
In six years, the company built a direct advertising operation across 15+ countries, assembled a team of 400+ professionals, and developed a portfolio of 100+ wellness products – all in markets, like Asia, LatAm, Africa, which most of the competitors hadn’t even considered worth entering. That expansion happened because one person looked at the affiliate industry, identified what was fundamentally broken about it, and decided to build an alternative.
That person is Rozhden Totskoinovfounder and CEO of INB.bio.
The man in front of the company
Before INB.bio existed, Rozhden launched a successful IT company. He came to the industry as an outsider with technical and operational depth, which turned out to be exactly the vantage point that let him see what industry insiders had stopped noticing.
Old: Rozhden Totskoinov INB.bio founder
Description: Rozhden Totskoinov INB.bio founder
What he saw was a structural problem.
- Networks claimed to serve emerging markets without understanding them.
- Call centers were outsourced to operators working from phonetically transliterated scripts.
- Partners lost money not because the markets were bad but because nobody had built anything real inside them.
- The infrastructure that was supposed to support affiliate campaigns existed mostly in sales presentations.
Rozhden watched this for long enough to understand it wasn’t going to fix itself. Genuine infrastructure is expensive. Genuine knowledge of exotic GEOs takes time. The path of least resistance was to outsource, simplify, and move on.
He decided not to take that path.
“I got tired of watching affiliates struggling with networks that didn’t actually understand the markets they claimed to serve,” Rozhden says. “The problem wasn’t the markets. The problem was that nobody was actually operating in them. I wanted to build something that did.”
INB.bio was founded on that intention: a direct advertiser that operates on the ground in every market it serves, with real teams, real infrastructure, and real accountability for what happens between an ad click and a customer’s front door.
The founding thesis
Old: INB.bio benefits
Description: INB.bio benefits
Rozhden’s strategic view when he launched INB.bio was specific and, at the time, contrarian.
Tier-1 markets in Western Europe and North America were getting harder and more expensive. CPMs were climbing. Competition was thick. The margins that had made affiliate marketing attractive five and ten years earlier were compressing. And yet the entire industry was crowding further into those markets, competing for smaller and smaller slices of the same audience.
Meanwhile, markets across Africa, Asia, and Latin America were sitting largely untouched. Rising middle classes with growing disposable income. Expanding internet penetration. Wellness awareness is growing alongside e-commerce adoption. Real consumer demand for products that were already proven in more developed markets and almost no established affiliate presence to serve that demand.
Rozhden saw the gap and moved into it.
“The future of affiliate marketing isn’t in fighting for scraps in oversaturated tier-1 markets,” he says. “It’s in becoming first movers in emerging markets, like Africa and Asia, where audiences are underserved, competition is light, and opportunity is massive. But you can’t do that from a laptop in Europe. You have to be there, hiring locals, understanding culture, building infrastructure.”
That last sentence is where most companies stop. Rozhden treated it as the starting point.
Building the operation
INB.bio’s expansion was not a process of adding countries to a platform. Each new market meant building from scratch: local teams recruited and trained, native call center operations established, warehousing and fulfillment set up, courier networks developed, and the regulatory and compliance requirements of each country specifically navigated.
- A product that converts into one market needs to be reformulated, repackaged, and repriced and licensed for another.
- A call center that works in one country needs entirely different scripts, different objection handling, and different cultural context for the next, so we only hire locals.
- A delivery network that performs in a major city needs a separate solution for smaller towns and rural areas.
Rozhden built INB.bio to handle all of that internally. Licensed in-house production. Native call center teams in each country. Owned delivery infrastructure in high-density markets. Local specialists who understand not just the language but the specific social and cultural dynamics that determine whether a COD customer picks up the package or turns the courier away at the door.
The product portfolio was built with the same discipline. Each of INB.bio’s 100+ wellness products went through local demand research, partner consultation, and a controlled pilot launch before reaching full rollout.
“We knew early on that the opportunity in these markets was real and that the window to enter before serious competition arrived was finite,” Rozhden says. “We moved fast because we had to, and we built properly because cutting corners in these markets costs you the market entirely.”
Leadership style and company culture
Rozhden runs INB.bio with a leadership philosophy that is practical and deeply ideological, the whole team is truly committed to the company’s core mission. He values specific knowledge over general capability, operational honesty over optimistic projections, and long-term partner relationships over short-term volume.
The company’s relationship with its affiliate partners reflects that directly. We deliver in-depth market research grounded in real data, including validated buyer personas and key market metrics. Our insights are further verified through focus groups, proven creatives we’ve tested, or fully turnkey solutions prepared on request. Our goal is not one-off projects, but long-term, trusted partnerships.
“Genuine partnership with affiliates is something rare in this industry,” Rozhden says. “We’ve maintained it by being honest about what we can deliver, building the operations to actually deliver it, and treating every market we enter as a long-term commitment rather than a short-term extraction. If a partner is running quality traffic, we want that relationship to last years, not months.”
That orientation toward long-term relationships over short-term numbers runs through the company’s hiring decisions, its market entry strategy, and how it manages performance across the network. The 400+ professionals at INB.bio are the people who make the operation function at the ground level. Rozhden built that team with the same logic he applied to market selection: depth over surface, genuine capability over the appearance of it.
Why the market timing created a durable advantage
When INB.bio entered most of its current markets, the competitive environment was sparse. There were local players without the product quality or operational sophistication to serve the demand well, and there were global networks without the genuine local presence to do it reliably. INB.bio occupied the space between them.
Six years later, that space is better understood and more contested. Other companies are now trying to figure out how to operate in the same markets. The difference is that INB.bio has six years of local relationships, operational refinement, regulatory knowledge, and brand trust in those markets. That’s not an advantage that can be closed quickly.
The 15+ GEOs INB.bio operates in today are not all at the same stage of development. Some are mature enough that the company has multiple years of performance data, optimized delivery networks, and established product lines. Others are newer entries where the infrastructure is still being refined. Rozhden manages that portfolio actively, allocating resources to markets that are scaling, refining operations in markets that need it, and evaluating new entry points where the same early-mover logic that built the company still applies.
“We’re not done,” Rozhden says simply. “The markets we operate in are still developing, the products we can offer are still expanding, and there are countries we haven’t entered yet where the same opportunity exists. The work we did in the first six years gives us a platform to move faster in the next six. We intend to use it.”
Rozhden Totskoinov is building a company around the belief that real infrastructure in real markets produces real results. The six years since he founded INB.bio have shown that belief to be correct. The company he built is still building. Join INB.bio today and be a part of the company’s future growth!
